Skip to main content
. 2011 May 30;1(1):e000016. doi: 10.1136/bmjopen-2010-000016

Table 2.

Incidence of trivalent inactivated influenza vaccine (TIV)-associated febrile convulsions and other febrile reactions in children aged 6 months to 4 years in Western Australia, by vaccine brand and formulation, for the period 8 March to 25 April 2010


Fluvax
Fluvax Junior
Combined Fluvax and Fluvax Junior (CF)
Influvac
CF vs Influvac
n/N* Rate/1000 TIV doses (95% CI) n/N Rate/1000 TIV doses (95% CI) n/N Rate/1000 TIV doses (95% CI) n/N Rate/1000 TIV doses (95% CI) RR (95% CI) p Value
Febrile convulsions ≤2 years 28/5754 4.9 (3.4 to 7.1) 23/2915 7.9 (5.3 to 11.8) 51/8669 5.9 (4.5 to 7.7) 0/2124 0 (0 to 1.8) Undefined <0.001
3–4 years 7/5015 1.4 (0.7 to 2.9) 4/413 9.7 (3.8 to 24.7) 11/5428 2.0 (1.1 to 3.6) 0/2596 0 (0 to 1.5) Undefined <0.05
All <5 years 35/10769 3.3 (2.4 to 4.6) 27/3327 8.1 (5.6 to 11.8) 62/14096 4.4 (3.4 to 5.6) 0/4720 0 (0 to 0.8) Undefined <0.0001
Other febrile reactions§ ≤2 years 282/5754 49.0 (43.7 to 54.9) 138/2915 47.3 (40.2 to 55.6) 420/8669 48.4 (44.1 to 53.1) 9/2124 4.2 (2.2 to 8.0) 11.4 (5.9 to 22.1) <0.0001
3–4 years 127/5015 25.3 (21.3 to 30.0) 11/413 26.6 (14.9 to 47.0) 138/5428 25.4 (21.5 to 29.9) 2/2596 0.8 (0.2 to 2.9) 33.0 (8.2 to 133.2) <0.0001
All <5 years 409/10769 38.0 (34.6 to 41.8) 149/3327 44.8 (38.3 to 52.4) 558/14096 39.6 (36.5 to 42.9) 11/4720 2.3 (1.3 to 4.1) 14.8 (8.3 to 26.7) <0.0001
*

n/N indicates number of febrile convulsions or other febrile reactions/adjusted number of doses given within age group and vaccine category.

RR, 95% CI and p value calculated for comparison of rates of adverse events for the combined Fluvax and Fluvax Junior group, versus Influvac. The RR and p value for the ‘All <5 years’ category is weighted for age.

Febrile convulsion presentations derived from notifications received via the AEFI reporting system and from emergency department ICD-10 diagnostic code R56.0 ‘febrile convulsion’.

§

‘Other febrile reactions’ derived from passive reports by doctors, other immunisation providers and parents to the AEFI reporting system.

AEFI, adverse event following immunisation; TIV, trivalent inactivated influenza vaccine.